blogger delicious digg diigo facebook googleplus linkedin netlog reddit twitter
Skip Navigation LinksJRI > Archive > July-September 2009, Volume 10, Issue 2 > Comparing the Effects of Clomiphene-HMG and Letrozole-HMG on Ovulation Induction in Infertile Women



Volume 10, Issue 2, Number 39 / July-September
(pages 109-114)


Comparing the Effects of Clomiphene-HMG and Letrozole-HMG on Ovulation Induction in Infertile Women




 Corresponding Author
Department of Gynecology and Obstetrics ,Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Faculty of Medical Tehran University of Medical Sciences, Tehran, Iran

Vali-e- Asar Reproductive Health Research Center,Tehran Medical Sciences University, Tehran, Iran

Vali-e- Asar Reproductive Health Research Center,Tehran Medical Sciences University, Tehran, Iran

Vali-e- Asar Reproductive Health Research Center,Tehran Medical Sciences University, Tehran, Iran

Received: 3/16/2009 Accepted: 6/29/2009

Related Articles
in Google Scholar in PubMed

 

Other Format
pdfPDF Full Text (En) pdfPDF Full Text (Fa) pdfePUB Full Text (En) pdfPDF Abstract (En) pdfPDF Abstract (Fa) pdf BibTeX pdfRefMan pdfEndNote xmlPMC XML online readerPMC Reader

 


Abstract
Introduction: Clomiphene Citrate has been one of the effective medications in the treatment of infertility but it has undesirable side effects, such as flushing, decreased cervical mucus production, impaired postcoital test (PCT) and multiple pregnancies. Letrozole is a newer drug and it improves cervical mucus production, increases endometrial thickness and reduces the risk for multiple pregnancies. Comparing the efficacy of clomiphene citrate versus letrozole for ovulation induction in patients with Polycystic Ovarian Disease (PCOD) was the objective of this study.Materials and Methods: This clinical trial study was done on 100 infertile, 20-35 year-old women with PCOD attending Vali-e-Asr Infertility Clinic from April 2003 to April 2007. The cases were candidates for intrauterine insemination (IUI) and signed a consent form to participate in the study. The cases were assigned to two groups through simple random sampling, the first group receiving clomiphen citrate plus HMG and the second one Letrozole plus HMG. Endometrial thickness, number of mature follicles, pregnancy rates, history of abortion and multiple pregnancies were recorded and compared in the two groups.Results: Comparing the two groups, the number of mature follicles (p=0.000), the risk for ovarian hyperstimulation (40% versus 14%, p=0.003) and abortions rates (37.5% versus 11.11%, p=0.048) were significantly higher in the clomiphene group. Differences in endometrial thickness and pregnancy rates (eight subjects in the clomiphene versus nine in the letrozole group) were of no statistical significance in the two groups.Conclusion: It seems that letrozole is a good substitute for clomiphene citrate, especially in patients at risk of abortion or ovarian hyperstimulation syndrome (OHSS), or in those who cannot tolerate clomiphene citrate. Further studies are needed to be done to fully suggest letrozole as the first line treatment for controlled ovarian hyperstimulation syndrome.

Keywords: HCG, Human menopausal genadotropin, Intra uterine insemination, Letrozole, Ovarian hyperstimulation syndrome, Ovulation induction, PCOD, Clomiphene citrate


To cite this article:



Figures, Charts, Tables

References
  1. Speroff L, Fritz MA. Clinical gynecologic endocrine-ology and infertility. 7th ed. Philadelphia: Lippincott Williams & Wilkins; c2005. Chapter 30, Parturition; p. 1097-132.
  2. Sohrabvand F, Ansari Sh, Bagheri M. Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease. Hum Reprod. 2006;21(6):1432-5.   [PubMed]
  3. Sh Tehrani Nejad E, Abediasl Z, Rashidi BH, Azimi Nekoo E, Shariat M, Amirchaghmaghi E. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphen citrate gonadotropins in controlled ovarian hyperstimulation: a prospective, simply randomized, clinical trial. J Assist Reprod Genet. 2008;25(5):187-90.   [PubMed]
  4. Ekerhovd E. [Ovulation induction by means of letrozole]. Tidsskr Nor Laegeforen. 2009;129(5):412-5. Norwegian.   [PubMed]
  5. Casper RF. Letrozole versus clomiphene citrate: which is better for ovulation induction? Fertil Steril. 2007. [Epub ahead of print]   [PubMed]
  6. Bao SH, Sheng SL, Peng YF, Lin QD. Effects of letrozole and clomiphene citrate on the expression of HOXA10 and integrin alpha v beta 3 in uterine epithelium of rats. Fertil Steril. 2009;91(1):244-8.   [PubMed]
  7. Topipat C, Choktanasiri W, Jultanmas R, Weerakiet S, Wongkularb A, Rojanasakul A. A comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on superovulation in Asian women with normal ovulatory cycles. Gynecol Endocrinol. 2008;24(3):145-50.   [PubMed]
  8. Jee BC, Ku SY, Suh CS, Kim KC, Lee WD, Kim SH. Use of letrozole versus clomiphene citrate combined with gonadotropins in intrauterine insemination cycles: a pilot study. Fertil Steril. 2006;85(6):1774-7.   [PubMed]
  9. Holzer H, Casper R, Tulandi T. A new era in ovulation induction. Fertil Steril. 2006;85(2):277-84.   [PubMed]
  10. Atay V, Cam C, Muhcu M, Cam M, Karateke A. Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. J Int Med Res. 2006;34(1):73-6.   [PubMed]
  11. Fisher SA, Reid RL, Van Vugt DA, Casper RF. A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women. Fertil Steril. 2002;78(2):280-5.   [PubMed]
  12. Fatemi HM, Kolibianakis E, Tournaye H, Camus M, Van Steirteghem AC, Devroey P. Clomiphene citrate versus letrozole for ovarian stimulation: a pilot study. Reprod Biomed Online. 2003;7(5):543-6.   [PubMed]
  13. Novak E, Berek JS, Hillard PA, Adashi EY. Novak`s Gynecology. 13th ed. Philadelphia: Lippincott Williams & Wilkins; 2002. Chapter 25, Parturition; p. 871-930.
  14. Danforth DN, Scott JR, Gibbs RS, Karlan BY, Haney AF. Danforth`s Obstetrics and Gynecology. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2003. Chapter 38, Parturition; p. 685-96.
  15. Cortinez A, De Carvalho I, Vantman D, Gabler F, Iniguez G, Vega M. Hormonal profile and endometrial morphology in letrozole-controlled ovarian hyper stimulation in ovulatory infertile patients. Fertil Steril. 2005;83(1):110-5.   [PubMed]
  16. Gregoriou O, Vlahos NF, Konidaris S, Papadias K, Botsis D, Creatsas GK. Randomized controlled trial comparing superovulation with letrozole versus recombinant follicle-stimulating hormone combined with intrauterine insemination for couples with unex-plained infertility who had failed clomiphene citrate stimulation and intrauterine insemination. Fertil Steril. 2008;90(3):678-83.   [PubMed]
  17. Al-Fozan H, Al-Khadouri M, Tan SL, Tulandi T. A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. Fertil Steril. 2004;82(6):1561-3.   [PubMed]
  18. Barroso G, Menocal G, Felix H, Rojas-Ruiz JC, Arslan M, Oehninger S. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate as adjuvants to recombinant follicle-stimulating hor-mone in controlled ovarian hyperstimulation: a pro-spective, randomized, blinded clinical trial. Fertil Steril. 2006;86(5):1428-31.   [PubMed]
  19. Begum MR, Ferdous J, Begum A, Quadir E. Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycys-tic ovarian syndrome. Fertil Steril. 2008 Jan 3. [Epub ahead of print].   [PubMed]
  20. Mitwally MF, Casper RF. Use of an aromatase inhibi-tor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril. 2001;75(2):305-9.   [PubMed]
  21. Sohrabvand F, Ansari Sh, Bagheri M. Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease. Hum Reprod. 2006;21(6):1432-5.



Home | About Us | Current Issue | Past Issues | Submit a Manuscript | Instructions for Authors | Subscribe | Search | Contact Us

"Journal of Reproduction & Infertility" is owned, published, and copyrighted by Avicenna Research Institute .
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

Journal of Reproductoin and Infertility (JRI) is a member of COMMITTEE ON PUBLICATION ETHICS . Verify here .

©2016 - eISSN : 2251-676X, ISSN : 2228-5482, For any comments and questions please contact us.